Curaleaf (OTCMKTS:CURLF) Shares Down 4.4% – Should You Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares traded down 4.4% during mid-day trading on Thursday . The stock traded as low as $9.53 and last traded at $9.56. Approximately 152,351 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 298,911 shares. The stock had previously closed at $10.00.

Analyst Upgrades and Downgrades

CURLF has been the topic of several recent research reports. Citigroup reiterated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. According to MarketBeat, Curaleaf currently has an average rating of “Strong Buy”.

Curaleaf Price Performance

The company has a fifty day simple moving average of $8.83 and a two-hundred day simple moving average of $8.04. The stock has a market capitalization of $2.32 billion, a price-to-earnings ratio of -76.30 and a beta of 1.57. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.73 and a current ratio of 1.52.

Curaleaf (OTCMKTS:CURLF) last released its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The company had revenue of $340.10 million for the quarter, compared to analyst estimates of $332.00 million. As a group, equities research analysts expect that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.